Chief Medical Officer Harold Bernstein exercised 15,000 shares, which were sold immediately for a total transaction value of approximately $690,300 on Feb. 2, 2026. Maze Therapeutics recently hit its ...

Maze Therapeutics (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, visits the Nasdaq MarketSite ...

In the first starred Times review from the islands, our critic finds intriguing twists on a cuisine that’s already fluid with Asian influences. Credit... Supported by By Ligaya Mishan Photographs and ...

Maze Therapeutics leverages its Compass platform to translate human genetic insights into de-risked, high-probability drug candidates. MZE829 targets APOL1-mediated kidney disease with a dual ...

The moment a guide dog in training took a field trip to a mirror maze has charmed internet viewers as she managed to solve the puzzle that often stumps even the most observant of humans. Poppy the ...

At first glance, it looks like a simple maze. In reality, it’s one of the most demanding precision competitions in the world. Competitors memorize layouts, perfect movements, and train for years to ...

There’s a personal story that Yale psychologist Brian Scholl often shares when he explains his scholarly interest in the vexing power of what he calls “unfinishedness,” or that nagging frustration you ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. If you’ve ever tried to lose weight in America, ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Strange Jigsaws is a stunningly clever and entertaining collection of puzzles that defy time and space Indie of the Week Strange Jigsaws It’s certainly true that Strange Jigsaws came out as long ago ...